TP53BP1 and neoplasm: Another early study suggesting that VRK1 is an upstream kinase for 53BP1 foci formation in response to DNA damage implies that specific VRK1 inhibitors might contribute to additional DNA damage accumulation in tumor cells, thereby leading to tumor-specific cell death [23].